Eiger BioPharmaceuticals, Inc. (EIGR) has a market capitalization of $2.55M and trades at $1.73. The 52-week range is 1.725-1.9.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-50.78, annual revenue of $15.77M.
The stock has a beta of 1.85, operates in the Healthcare sector.
